Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence

Jan 16, 2024

News provided by

09 Jun, 2023, 17:15 ET

Share this article

DUBLIN, June 9, 2023 /PRNewswire/ -- The "Global Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Cumulative Impact of High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.

The Global Opioid Induced Constipation Market was estimated at USD 62.12 million in 2022, and is expected to reach USD 65.95 million in 2023. It is projected to rise at a CAGR of 6.62% to reach USD 103.78 million by 2030. The cumulative impact of COVID-19, the Russia-Ukraine conflict, and high inflation is expected to have significant long-term effects on the market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic.

Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of high inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & CoverageThis research report categorizes the Global Opioid Induced Constipation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

FPNV Positioning MatrixThe FPNV Positioning Matrix is essential for assessing the Global Opioid Induced Constipation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share AnalysisThe Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Company Usability ProfilesThe report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Opioid Induced Constipation Market, including:

The report provides insights on the following pointers:

The report answers questions such as:

Key Topics Covered

1. Preface2. Research Methodology3. Executive Summary4. Market Overview5. Market Insights6. Opioid Induced Constipation Market, by Active Ingredients7. Opioid Induced Constipation Market, by Drug Class8. Opioid Induced Constipation Market, by Mode of Administration9. Opioid Induced Constipation Market, by Distribution Channel10. Americas Opioid Induced Constipation Market11. Asia-Pacific Opioid Induced Constipation Market12. Europe, Middle East & Africa Opioid Induced Constipation Market13. Competitive Landscape14. Company Usability Profiles15. Appendix16. List of Figures17. List of Tables

For more information about this report visit https://www.researchandmarkets.com/r/favn66

Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets